Vitrafy, Australia’s exciting new Bio Tech Company leading the way in innovative new patient orientated outcomes.
Vitrafy is revolutionising the delivery of existing and emerging cell-based therapies from the research laboratory to the patient bedside. Giving your loved one the best chance of coming home.
HOW WE DO IT:
Cryopreservation plays a critical role in the biomedical life science industry. Current and emerging cellular therapies require successful cryopreservation of sensitive biological material that to-date, have had notoriously low and inconsistent success rates.
Vitrafy have developed new, fully patented, cold chain solutions for the advancement in biomedical cryopreservation. These include a cryopreservation algorithm, freezing apparatus’, thawing apparatus’, tailored racking and packing solutions and a completely integrated software solution that includes data collection, reporting and processing automation.
Company’s Keywords:
biotech, cellbased therapies, research laboratory
<11
<
<2018